-
DiscoveryProbe Bioactive Compound Library Plus: Applied Work
2026-05-25
The DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) accelerates target validation and pathway analysis with 5,072 pre-dissolved, cell-permeable small molecules, available ready-to-screen. This guide translates recent advances in ligand discovery and high-throughput screening into actionable protocols, comparative insights, and troubleshooting tips for cancer research, apoptosis assays, and beyond.
-
ISRIB (trans-isomer): A Paradigm Shift in Memory & ISR Modul
2026-05-25
This thought-leadership article explores the mechanistic and translational promise of ISRIB (trans-isomer) as a PERK inhibitor and integrated stress response modulator. By integrating new mechanistic insights, key findings from recent neurobiology research, and practical guidance for translational researchers, the piece positions APExBIO's ISRIB (trans-isomer) as an indispensable tool for advancing ER stress research, apoptosis assays, and cognitive enhancement studies—while offering a framework for navigating the evolving competitive landscape and future directions.
-
Dibutyryl-cAMP, Sodium Salt: Optimizing cAMP Pathway Researc
2026-05-24
Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) provides a powerful, stable, and cell-permeable solution for dissecting cAMP-mediated signaling in both routine and advanced experimental workflows. This article offers hands-on guidance, protocol enhancements, and troubleshooting insights to maximize reproducibility and data quality in applications from neuronal reprogramming to inflammation and tauopathy studies.
-
Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53
2026-05-23
This study demonstrates that Obacunone, a citrus-derived compound, induces ferroptosis and suppresses ovarian cancer cell proliferation by modulating the Akt/p53 signaling pathway. The findings provide mechanistic insight into ferroptosis regulation in cancer and highlight the potential for targeting Akt signaling in future therapeutic strategies.
-
SB203580: Precision p38 MAPK Inhibition for Advanced Assays
2026-05-22
Unlock the full power of SB203580 in dissecting p38 MAPK signaling, enabling robust workflows in neuroprotection, multidrug resistance, and inflammation research. This guide translates recent reference breakthroughs into hands-on tips, experimental enhancements, and troubleshooting advice for reproducible, high-impact results.
-
Hesperadin: Precision Aurora B Kinase Inhibitor in Mitosis R
2026-05-22
Hesperadin enables high-resolution dissection of mitotic checkpoints and spindle assembly, making it indispensable for cancer and cell cycle research. Its robust, ATP-competitive inhibition of Aurora B kinase delivers reproducible arrest of mitotic progression, as validated in both primary literature and practical protocols.
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor Pr
2026-05-21
Wang et al. (2018) systematically demonstrated that genotype III grass carp reovirus (GCRV104) enters host cells through clathrin-mediated endocytosis in a dynamin- and pH-dependent manner. Notably, this entry route does not require actin cytoskeleton disruption, providing new mechanistic insight for antiviral strategy development and cytoskeletal research.
-
1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src Kinase P
2026-05-21
As a rigorously validated negative control, 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) empowers researchers to dissect Src kinase signaling pathway specificity with confidence. This research use only chemical, supplied by APExBIO, optimizes experimental clarity and reproducibility in kinase inhibitor studies.
-
Dasatinib (BMS-354825): Applied Protocols in Cancer Research
2026-05-20
Dasatinib (BMS-354825) stands out as a precision tool for dissecting Src and Bcr-Abl kinase signaling in cancer models, from chronic myeloid leukemia to solid tumors. This article translates recent breakthroughs—such as the SNAI1–PIK3R2/p-EphA2 axis in TETs—into actionable workflows, troubleshooting guidance, and advanced applications that empower researchers to probe EMT, metastasis, and therapeutic resistance with confidence.
-
Vardenafil HCl Trihydrate: Enabling Proteoform-Resolved PDE5
2026-05-20
Explore how Vardenafil HCl Trihydrate is redefining PDE5 inhibition assays for translational research. This article bridges mechanistic insights, cutting-edge proteomics, and practical strategy, guiding teams to leverage APExBIO’s potent, selective inhibitor in high-fidelity, proteoform-specific models of cGMP signaling and smooth muscle relaxation.
-
Genistein as a Precision Tool: Decoding Cytoskeleton-Driven
2026-05-19
Explore how Genistein, a selective tyrosine kinase inhibitor, advances research on cytoskeleton-mediated autophagy and cancer chemoprevention. This article bridges molecular mechanisms with practical assay guidance, revealing insights not covered in standard protocols.
-
Sildenafil Citrate: Selective PDE5 Inhibitor for Vascular Re
2026-05-19
Sildenafil Citrate is a potent, selective cGMP-specific phosphodiesterase type 5 inhibitor with nanomolar potency. It enables precise modulation of vascular smooth muscle relaxation and cGMP signaling in both in vitro and in vivo models. This article delivers verifiable, protocol-ready insights for cardiovascular and proteoform-targeted research.
-
CDK4/6 and BET Inhibitor Synergy Suppresses PDAC via Wnt/TGF
2026-05-18
Gu et al. (2025) demonstrate that combining CDK4/6 and BET inhibition produces a synergistic suppression of pancreatic ductal adenocarcinoma growth and epithelial-to-mesenchymal transition (EMT) by targeting the GSK3β-mediated Wnt/β-catenin pathway and interfering with TGF-β/Smad signaling. This work highlights a potential combinatorial therapeutic strategy for overcoming metastasis and drug resistance in PDAC.
-
AT13387: Precision Hsp90 Inhibition for Cancer Biology Workf
2026-05-18
AT13387, a next-generation Hsp90 inhibitor from APExBIO, delivers nanomolar potency and robust tumor selectivity for advanced cancer biology research. This guide provides actionable protocols, troubleshooting tips, and novel workflow integrations inspired by recent mechanistic findings in regulated cell death.
-
ML-7 Hydrochloride (SKU A3626): Reliable MLCK Inhibition in
2026-05-17
This scenario-driven guide addresses critical challenges in cell viability and cytotoxicity assays, illustrating how ML-7 hydrochloride (SKU A3626) from APExBIO offers reproducible, data-backed solutions for myosin light chain kinase (MLCK) pathway studies. By grounding protocol decisions in quantitative evidence and real laboratory contexts, researchers can optimize assay sensitivity and workflow reliability using ML-7 hydrochloride.